Literature DB >> 22249281

Modified laparoscopic extraperitoneal uterine suspension to anterior abdominal wall: the easier way to treat uterine prolapse.

Gang Chen1, Dabao Wu, Weidong Zhao, Weiping Hu, Jia Li, Bin Ling.   

Abstract

INTRODUCTION AND HYPOTHESIS: To report the outcomes of modified laparoscopic extraperitoneal uterine suspension to anterior abdominal wall for uterine prolapse using mesh.
METHODS: Twenty-two patients with uterovaginal prolapse, stage 2 or greater according to pelvic organ prolapse quantification (POP-Q), and with desire for uterine preservation, underwent modified laparoscopic extraperitoneal uterine suspension to the anterior abdominal wall bilaterally using mesh. The outcomes were measured by POP-Q and quality-of-life questionnaires. Intraoperative or postoperative complications were also observed.
RESULTS: Patient age was 61.4 ± 12 years, and parity was 3.3 ± 1.8. After surgery, there was significant improvement in POP-Q measurements of Ba, Bp, and C (P < 0.001). The objective cure rate at 1 year was 100%. A significant improvement in quality-of-life scores was observed (P < 0.001). There were no major intraoperative or postoperative complications. However, all patients reported postoperative dragging pain at the points of puncture ports where the mesh was fixed to the abdominal wall. The visual analog scale decreased from a mean 3-day score of 2.9-0 at 1-month follow-up.
CONCLUSIONS: Modified laparoscopic extraperitoneal uterine suspension to the anterior abdominal wall using mesh is a feasible and effective method for treating uterine prolapse and is easy to perform.

Entities:  

Mesh:

Year:  2012        PMID: 22249281     DOI: 10.1007/s00192-012-1661-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  14 in total

1.  Uterine prolapse and prolapse of the vaginal vault treated by sacral hysteropexy.

Authors:  H G ARTHURE; D SAVAGE
Journal:  J Obstet Gynaecol Br Emp       Date:  1957-06

2.  Laparoscopic uterine sling suspension: a new technique of uterine suspension in women desiring surgical management of uterine prolapse with uterine conservation.

Authors:  A Cutner; R Kearney; A Vashisht
Journal:  BJOG       Date:  2007-07-06       Impact factor: 6.531

3.  Vault-suspension.

Authors:  H G E ARTHURE
Journal:  Proc R Soc Med       Date:  1949-06

Review 4.  Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis.

Authors:  X Jia; C Glazener; G Mowatt; G MacLennan; C Bain; C Fraser; J Burr
Journal:  BJOG       Date:  2008-08-19       Impact factor: 6.531

Review 5.  Pelvic organ prolapse.

Authors:  J Eric Jelovsek; Christopher Maher; Matthew D Barber
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

6.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

7.  Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7).

Authors:  M D Barber; M D Walters; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

8.  Laparoscopic treatment of pelvic floor defects in women of reproductive age.

Authors:  Renato Seracchioli; Jacques-Alain Hourcabie; Federico Vianello; Francesca Govoni; Paola Pollastri; Stefano Venturoli
Journal:  J Am Assoc Gynecol Laparosc       Date:  2004-08

9.  Abdominal sacrohysteropexy in young women with uterovaginal prolapse: long-term follow-up.

Authors:  Emmanuel Barranger; Xavier Fritel; Alain Pigne
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

10.  Laparoscopic sacrocervicopexy for the treatment of uterine prolapse: a retrospective case series report.

Authors:  Peter L Rosenblatt; David Chelmow; Tanaz R Ferzandi
Journal:  J Minim Invasive Gynecol       Date:  2008-03-20       Impact factor: 4.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.